Top Story

NYU Langone names cancer center director

November 22, 2014

Benjamin G. Neel, MD, PhD, has been named director of the Laura and Isaac Perlmutter Cancer Center at NYU Langone Medical Center.

The appointment will be effective Jan. 1.

Edith Perez, MD In the Journals

Trastuzumab plus adjuvant chemotherapy improved OS DFS in HER 2 positive breast cancer

November 21, 2014
The addition of trastuzumab to adjuvant chemotherapy conferred “substantial and durable improvement in survival” among women with early-stage…
In the Journals

Endoscopists regularly overuse colonoscopy screenings for colorectal cancer

November 21, 2014
Endoscopists commonly recommended more frequent colonoscopy screenings and surveillance for colorectal cancer than current recommended guidelines, according to study…
Meeting News Coverage

American Indians, Alaskan Natives experienced shorter cancer survival, even with equal access to care

November 21, 2014
Cancer survivors of American Indian or Alaskan Native descent demonstrated poorer rates of 5- and 10-year cancer survival than non-Hispanic whites even when they had…
Jeffrey Kullgren, MD In the Journals

Lottery incentive improved fecal occult blood test completion rates

November 21, 2014
Among several different financial incentives tested, a lottery-style cash reward increased rates of completion of fecal occult blood tests for colon cancer screening…
More News Headlines »
Low Risk AAMDS

Treatment Decision-Making through the Spectrum of MDS: Case 1 Low Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain MDS…
More »
Meeting News Coverage Video
thumbnail for video 3886443649001

Risk stratification guidelines help determine treatment for thyroid cancer

November 11, 2014
Fabian Pitoia, MD,  head of the thyroid section of the division of endocrinology at the Hospital de Clinicas of…
More »
Activity cover

Targeted Therapy and Immunotherapy in the Management of Metastatic Melanoma: 2014 Updates

This activity is supported by an educational grant from Merck & Co., Inc.

Melanoma remains a challenging condition for clinicians. An array of targeted therapies and immunotherapy are in…
More »